Haleon has reported high single digit revenue growth in its vitamin and mineral supplements (VMS) category across Asia-Pacific in Q1 this year, due to the demand for Centrum and Caltrate especially in China, South East Asia, and Taiwan.
Haleon, the maker of vitamin and mineral supplement brands Centrum and Caltrate, said revenue growth haw gone up by over 20 per cent for its VMS portfolio in South East Asia, Taiwan, and India.
Haleon, formerly GSK Consumer Health, has entered into a partnership with CREA – an e-commerce enabler to increase the presence brands such as Centrum across Thailand’s e-commerce and social media platforms.
The vitamin and mineral (VMS) category will continue to trend towards meeting the needs of individuals of different ages, life stages, and gender, according to GSK consumer healthcare, which highlighted how this is driving its NPD.
